BioCentury
ARTICLE | Company News

Hebrew University of Jerusalem deal

June 22, 2009 7:00 AM UTC

Investment group Aurum Ventures MKI Ltd. received an option from the university's Yissum Research and Development Ltd. to license an oral reformulation of an undisclosed injectable drug that uses Yis...